FindMyKOL
Clinical trialNCT02037152WithdrawnInterventional

Smartphone-based Mindfulness Training for Chronic Pain

NCT02037152 is an interventional trial sponsored by University of California, San Francisco. As of 18 Nov 2026, it was withdrawn. It studies Chronic Pain. The registry lists an enrollment of 0 participants at 1 site in 1 country. The registry lists a start date of 31 Jan 2014 and a primary completion date of 31 May 2014.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02037152
FieldValue
Registry IDNCT02037152
StatusWithdrawn
Study typeInterventional trial
Lead sponsorUniversity of California, San Francisco
Enrollment0
Registered sites1
Countries1
ConditionsChronic Pain
Start31 Jan 2014
Primary completion31 May 2014
Study completion31 May 2014
Last update posted27 Oct 2014

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test a smartphone-based mindfulness training program for chronic pain. Research participants use a 20 minute app-guided audio program six days per week. The study hypothesis is that training in this technique over a period of four weeks will reduce pain interference with daily life activities. This study does not require any travel or in-person contact with research staff-- all elements of the study are completed on the participant's smartphone.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • University of California, San Francisco

    San Francisco

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02037152

Each answer restates registry values shown on this page.

What is NCT02037152?

NCT02037152 is an interventional trial sponsored by University of California, San Francisco. It studies Chronic Pain.

Who leads NCT02037152?

The registry names Ida Sim, MD, PhD (principal investigator, University of California, San Francisco) as the overall official.

Where does NCT02037152 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT02037152 end?

The registry lists a primary completion date of 31 May 2014 and a study completion date of 31 May 2014. The sponsor last updated the record on 27 Oct 2014.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.